The estimated Net Worth of Harpreet Grewal is at least $5.17 Millón dollars as of 4 September 2024. Mr. Grewal owns over 782 units of Penumbra Inc stock worth over $1,793,074 and over the last 9 years he sold PEN stock worth over $3,183,448. In addition, he makes $195,593 as Independent Director at Penumbra Inc.
Sign up
Mr. Grewal PEN stock SEC Form 4 insiders trading
Harpreet has made over 23 trades of the Penumbra Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently he sold 782 units of PEN stock worth $159,614 on 4 September 2024.
The largest trade he's ever made was selling 4,500 units of Penumbra Inc stock on 21 August 2017 worth over $371,925. On average, Harpreet trades about 607 units every 73 days since 2015. As of 4 September 2024 he still owns at least 8,863 units of Penumbra Inc stock.
You can see the complete history of Mr. Grewal stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Harpreet Grewal biography
Harpreet S. Grewal serves as Independent Director of the Company. Mr. Grewal has served as Chief Operating Officer of Volante Technologies Inc., a global provider of software for the integration, processing and orchestration of payments and financial messages, where he also serves on the Board of Directors and served as Executive in Residence from April 2018 to March 2019. From February 2016 through April 2017, Mr. Grewal served as General Manager of Constant Contact, Inc. (Constant Contact), a technology company primarily focused on marketing tools and a wholly-owned indirect subsidiary of Endurance International Group Holdings, Inc. (Endurance). Prior to the acquisition of Constant Contact by Endurance, from 2010 to February 2016, Mr. Grewal served as Executive Vice President and Chief Financial Officer of Constant Contact. In December 2019, Mr. Grewal agreed to settle litigation instituted by the SEC alleging that Mr. Grewal violated the antifraud provisions of Section 17(a) of the Securities Act, Section 10(b) of the Exchange Act and Rule 10b-5 promulgated under the Exchange Act, and violated, or aided and abetted the violation of, the reporting, record-keeping and internal controls requirements of Section 13(a), Section 13(b)(2)(A) and related rules under the Exchange Act in connection with his position at Constant Contact. Without admitting or denying the SEC’s allegations, Mr. Grewal consented to the entry of a Final Judgment that permanently enjoined him from future violations of Section 17(a) of the Securities Act and from aiding and abetting future violations of Section 13(a) or Section 13(b)(2)(A) of the Exchange Act, and required him to pay a fine of $350,000, including a $100,000 civil penalty. From 2008 to 2009
What is the salary of Harpreet Grewal?
As the Independent Director of Penumbra Inc, the total compensation of Harpreet Grewal at Penumbra Inc is $195,593. There are 12 executives at Penumbra Inc getting paid more, with Johanna Roberts having the highest compensation of $2,556,370.
How old is Harpreet Grewal?
Harpreet Grewal is 53, he's been the Independent Director of Penumbra Inc since 2015. There are 9 older and 8 younger executives at Penumbra Inc. The oldest executive at Penumbra Inc is Don Kassing, 78, who is the Presiding Independent Director.
What's Harpreet Grewal's mailing address?
Harpreet's mailing address filed with the SEC is ONE PENUMBRA PLACE, , ALAMEDA, CA, 94502.
Insiders trading at Penumbra Inc
Over the last 9 years, insiders at Penumbra Inc have traded over $197,637,326 worth of Penumbra Inc stock and bought 700 units worth $109,480 . The most active insiders traders include Adam Elsesser, Arani Bose y James Robert Pray. On average, Penumbra Inc executives and independent directors trade stock every 9 days with the average trade being worth of $2,030,383. The most recent stock trade was executed by Harpreet Grewal on 4 September 2024, trading 782 units of PEN stock currently worth $159,614.
What does Penumbra Inc do?
penumbra is a specialty interventional therapies company that develops and markets innovative medical devices to treat challenging medical conditions with significant unmet clinical needs. we design our therapies to provide our specialist physician customers with improved clinical outcomes through faster and safer procedures at significant overall cost savings to the healthcare system. today we have over 1,000 employees with sales operations in north america, europe, australia and asia.
What does Penumbra Inc's logo look like?
Complete history of Mr. Grewal stock trades at Penumbra Inc
Penumbra Inc executives and stock owners
Penumbra Inc executives and other stock owners filed with the SEC include:
-
Johanna Roberts,
Executive Vice President, General Counsel, Secretary -
Maggie Yuen,
Chief Financial Officer -
Adam Elsesser,
Chairman of the Board, Chief Executive Officer -
Lynn Rothman,
Executive Vice President, Chief Business Officer -
Maggie S. Yuen,
Chief Financial Officer -
James Pray,
President, International -
Arani Bose,
Chief Innovator, Director -
Johanna Roberts,
Exec. VP, Gen. Counsel & Sec. -
Lambert Shiu,
Chief Accounting Officer -
Janet Leeds,
Independent Director -
Surbhi Sarna,
Independent Director -
Adam Elsesser,
Co-Founder, Chairman, Pres & CEO -
Harpreet Grewal,
Independent Director -
Bridget O'Rourke,
Independent Director -
Thomas Wilder,
Independent Director -
Don Kassing,
Presiding Independent Director -
Lambert Shiu,
Chief Accounting Officer -
Gita Barry,
Exec. VP & GM of Immersive Healthcare -
Ben Tompkins,
Exec. VP of Devel. -
Shruthi Narayan,
Director of Marketing - Vascular -
Dr. Arani Bose M.D.,
Co-Founder & Director -
Jee Hamlyn-Harris,
Investor Relations Officer -
Corey L. Teigen M.D.,
Chief Scientific Officer -
Ben Sorci,
Exec. VP of Operations -
Kevin James Sullivan,
Director -
Robert D. Evans,
EVP, Gen. Counsel & Secretary -
Daniel Donen Davis,
President, North America -
Sridhar Kosaraju,
President -
Walter Charles Wang,
Director